_version_ 1784676752448028672
author Yoon, Jin Gu
Yoo, Jin Sae
Lee, Jungmin
Hyun, Hak-Jun
Seong, Hye
Noh, Ji Yun
Cheong, Hee Jin
Kim, Woo Joo
Kim, Young Rong
Heo, Jung Yeon
Bae, Joon-Yong
Cui, Chunguang
Lee, Sohyun
Park, Man-Seong
Song, Joon Young
author_facet Yoon, Jin Gu
Yoo, Jin Sae
Lee, Jungmin
Hyun, Hak-Jun
Seong, Hye
Noh, Ji Yun
Cheong, Hee Jin
Kim, Woo Joo
Kim, Young Rong
Heo, Jung Yeon
Bae, Joon-Yong
Cui, Chunguang
Lee, Sohyun
Park, Man-Seong
Song, Joon Young
author_sort Yoon, Jin Gu
collection PubMed
description
format Online
Article
Text
id pubmed-8957381
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89573812022-03-28 Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment Yoon, Jin Gu Yoo, Jin Sae Lee, Jungmin Hyun, Hak-Jun Seong, Hye Noh, Ji Yun Cheong, Hee Jin Kim, Woo Joo Kim, Young Rong Heo, Jung Yeon Bae, Joon-Yong Cui, Chunguang Lee, Sohyun Park, Man-Seong Song, Joon Young J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-06 2022-03-26 /pmc/articles/PMC8957381/ /pubmed/35351541 http://dx.doi.org/10.1016/j.jinf.2022.03.022 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Yoon, Jin Gu
Yoo, Jin Sae
Lee, Jungmin
Hyun, Hak-Jun
Seong, Hye
Noh, Ji Yun
Cheong, Hee Jin
Kim, Woo Joo
Kim, Young Rong
Heo, Jung Yeon
Bae, Joon-Yong
Cui, Chunguang
Lee, Sohyun
Park, Man-Seong
Song, Joon Young
Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
title Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
title_full Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
title_fullStr Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
title_full_unstemmed Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
title_short Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
title_sort viable sars-cov-2 shedding under remdesivir and dexamethasone treatment
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957381/
https://www.ncbi.nlm.nih.gov/pubmed/35351541
http://dx.doi.org/10.1016/j.jinf.2022.03.022
work_keys_str_mv AT yoonjingu viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT yoojinsae viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT leejungmin viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT hyunhakjun viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT seonghye viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT nohjiyun viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT cheongheejin viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT kimwoojoo viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT kimyoungrong viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT heojungyeon viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT baejoonyong viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT cuichunguang viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT leesohyun viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT parkmanseong viablesarscov2sheddingunderremdesiviranddexamethasonetreatment
AT songjoonyoung viablesarscov2sheddingunderremdesiviranddexamethasonetreatment